The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention
Ranjini Sankaranarayanan(South Dakota State University), G. Jayarama Bhat(Biogen (United States))
Cited by 77
Related Papers
Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer
|International Journal of Oncology|2017|90
Aspirin acetylates multiple cellular proteins in HCT-116 colon cancer cells: Identification of novel targets
|International Journal of Oncology|2011|63
Aspirin inhibits glucose-6-phosphate dehydrogenase activity in HCT 116 cells through acetylation: Identification of aspirin-acetylated sites
|Molecular Medicine Reports|2016|44
A Role for the Hydroxybenzoic Acid Metabolites of Flavonoids and Aspirin in the Prevention of Colorectal Cancer
|Open PRAIRIE (South Dakota State University)|2021|0